UpdatesPress Release
Alembic Pharma received USFDA final approval for Prucalopride Tablets, for chronic constipation.
Alembic Pharmaceuticals LimitedAPLLTD · Filed with the exchange
The drug targets an estimated market of ~₹830 Cr, providing a significant new opportunity.
No comments yet. Be the first.